FR2476087A1
(fr)
|
1980-02-18 |
1981-08-21 |
Roussel Uclaf |
Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
|
GB9108279D0
(en)
|
1991-04-18 |
1991-06-05 |
Ucb Sa |
A method of preparing 1h-benzimidazoles
|
CN100358883C
(zh)
|
1998-06-02 |
2008-01-02 |
中国科学院上海有机化学研究所 |
含有β位三氟甲基基团的五元芳香杂环化合物及其合成
|
FR2792316B1
(fr)
|
1999-04-13 |
2001-06-22 |
Synthelabo |
Derives de 1-aminoethylindole, leur preparation et leur application en therapeutique
|
CA2426952C
(en)
|
2000-11-02 |
2012-06-26 |
Sloan-Kettering Institute For Cancer Research |
Small molecule compositions for binding to hsp90
|
US20070129334A1
(en)
|
2001-10-30 |
2007-06-07 |
Conforma Therapeutics Corporation |
Orally Active Purine-Based Inhibitors of Heat Shock Protein 90
|
AU2002356922A1
(en)
|
2001-11-09 |
2003-05-26 |
Conforma Therapeutics Corporation |
Hsp90-inhibiting zearalanol compounds and methods of producing and using same
|
ES2324207T3
(es)
|
2002-07-11 |
2009-08-03 |
Gea Bgr Energy System India Ltd. |
Filtro de cuerpos extraños con un extractor de cuerpos extraños giratorio.
|
US7037522B2
(en)
|
2002-09-27 |
2006-05-02 |
Western Holdings, L.L.C. |
Nocturnal muscle enhancing composition and method
|
GB0228417D0
(en)
|
2002-12-05 |
2003-01-08 |
Cancer Rec Tech Ltd |
Pyrazole compounds
|
GB0229618D0
(en)
|
2002-12-19 |
2003-01-22 |
Cancer Rec Tech Ltd |
Pyrazole compounds
|
WO2004072080A1
(en)
|
2003-02-10 |
2004-08-26 |
Cellular Genomics, Inc. |
Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of hsp90 complex activity
|
GB0309637D0
(en)
|
2003-04-28 |
2003-06-04 |
Cancer Rec Tech Ltd |
Pyrazole compounds
|
WO2005009345A2
(en)
|
2003-06-13 |
2005-02-03 |
Kosan Biosciences, Inc. |
2-desmethyl ansamycin compounds
|
GB0315111D0
(en)
|
2003-06-27 |
2003-07-30 |
Cancer Rec Tech Ltd |
Substituted 5-membered ring compounds and their use
|
EP1642880B1
(en)
|
2003-06-27 |
2013-09-04 |
Kyowa Hakko Kirin Co., Ltd. |
Hsp90 family protein inhibitors
|
GB0315657D0
(en)
|
2003-07-03 |
2003-08-13 |
Astex Technology Ltd |
Pharmaceutical compounds
|
AU2004200774A1
(en)
|
2003-07-07 |
2005-01-27 |
Holyrood Exports Pty Ltd |
Padlock Protector
|
JPWO2005006322A1
(ja)
|
2003-07-11 |
2006-08-24 |
コニカミノルタオプト株式会社 |
光ピックアップ装置、光ピックアップ装置に用いられる光学素子、及び光学素子の製造方法
|
EP1675861B1
(en)
|
2003-08-29 |
2015-12-23 |
Vernalis (R&D) Ltd. |
Pyrimidothiophene compounds
|
US6855705B1
(en)
|
2003-11-12 |
2005-02-15 |
Kosan Biosciences, Inc. |
11-O-methylgeldanamycin compounds
|
DE10354133A1
(de)
|
2003-11-19 |
2005-06-23 |
Phoenix Ag |
Fördergurt
|
ES2409351T3
(es)
|
2003-12-23 |
2013-06-26 |
Infinity Discovery, Inc. |
Análogos de ansamicinas que contienen benzoquinona para el tratamiento de cáncer
|
US20060019941A1
(en)
|
2003-12-23 |
2006-01-26 |
Infinity Pharmaceuticals, Inc. |
Analogs of benzoquinone-containing ansamycins and methods of use thereof
|
WO2005072766A2
(en)
|
2004-01-27 |
2005-08-11 |
Boys Town National Research Hospital |
Peptides that bind to hsp90 proteins
|
JP2005225787A
(ja)
|
2004-02-12 |
2005-08-25 |
Nippon Kayaku Co Ltd |
Hsp90阻害剤
|
JP4254633B2
(ja)
|
2004-06-28 |
2009-04-15 |
株式会社イトーキ |
回転椅子の回転規制装置
|
GB0416168D0
(en)
|
2004-07-20 |
2004-08-18 |
Vernalis Cambridge Ltd |
Pyrmidothiophene compounds
|
US7342093B2
(en)
|
2004-07-23 |
2008-03-11 |
University Of Massachusetts |
Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins
|
AU2005266494B2
(en)
|
2004-07-27 |
2009-09-10 |
Novartis Ag |
Inhibitors of Hsp90
|
AR050084A1
(es)
|
2004-07-27 |
2006-09-27 |
Novartis Ag |
Derivados de bencimidazolona como inhibidores de hsp90
|
KR101045324B1
(ko)
|
2004-08-11 |
2011-06-30 |
한국생명공학연구원 |
젤다나마이신 유도체 및 그 생합성 방법
|
DE102004039280A1
(de)
|
2004-08-13 |
2006-02-23 |
Merck Patent Gmbh |
1,5-Diphenyl-pyrazole
|
US7208630B2
(en)
|
2004-10-27 |
2007-04-24 |
University Of Kansas |
Heat shock protein 90 inhibitors
|
US7422759B2
(en)
|
2004-11-03 |
2008-09-09 |
K2 Concepts, Inc. |
Anti-microbial compositions and methods of making and using the same
|
US7608594B2
(en)
|
2004-11-03 |
2009-10-27 |
University Of Kansas |
Novobiocin analogues as anticancer agents
|
US7622451B2
(en)
|
2004-11-03 |
2009-11-24 |
University Of Kansas |
Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
|
WO2006055760A1
(en)
|
2004-11-18 |
2006-05-26 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate hsp90 activity
|
FR2880540B1
(fr)
|
2005-01-13 |
2008-07-11 |
Aventis Pharma Sa |
Utilisation de derives de la purine comme inhibiteurs de la proteine hsp90
|
GB0501535D0
(en)
|
2005-01-25 |
2005-03-02 |
Vernalis R&D Ltd |
Pyrimidothiophene compounds
|
US7834181B2
(en)
|
2005-02-01 |
2010-11-16 |
Slaon-Kettering Institute For Cancer Research |
Small-molecule Hsp90 inhibitors
|
DE102005007304A1
(de)
|
2005-02-17 |
2006-08-24 |
Merck Patent Gmbh |
Triazolderivate
|
FR2882361A1
(fr)
|
2005-02-22 |
2006-08-25 |
Aventis Pharma Sa |
Nouveaux derives de 3-aryl-1,2-benzisoxazole, compositions les contenant et leur utilisation
|
PL1856057T3
(pl)
|
2005-02-25 |
2015-04-30 |
Esanex Inc |
Pochodne tetrahydroindolonu i tetrahydroindazolonu
|
WO2006090094A1
(en)
|
2005-02-28 |
2006-08-31 |
Vernalis R & D Ltd |
Pyrimidothiophene compounds for use as hsp90 inhibitors
|
CN101160291B
(zh)
|
2005-03-09 |
2012-09-05 |
日本化药株式会社 |
作为hsp90抑制剂的***衍生物
|
EP1863769A4
(en)
|
2005-03-11 |
2009-03-18 |
Univ Colorado |
HSP90 INHIBITORS, METHOD FOR THE PRODUCTION THEREOF AND THEIR APPLICATIONS
|
JPWO2006100907A1
(ja)
|
2005-03-22 |
2008-09-04 |
松下電器産業株式会社 |
撮像装置および携帯無線通信端末
|
JP2008137894A
(ja)
|
2005-03-22 |
2008-06-19 |
Nippon Kayaku Co Ltd |
新規なアセチレン誘導体
|
JP2008534609A
(ja)
|
2005-03-30 |
2008-08-28 |
コンフォーマ・セラピューティクス・コーポレイション |
Hsp90阻害剤としてのアルキニルピロロピリミジンおよび関連類似体
|
FR2884252B1
(fr)
|
2005-04-08 |
2007-05-18 |
Aventis Pharma Sa |
Nouveaux derives d'isoindoles, compositions les contenant, leur preparation et leurs utilisations pharmaceutiques notamment en tant qu'inhibiteurs d'activites de la proteine chaperone hsp90
|
EP1883402A2
(en)
|
2005-04-13 |
2008-02-06 |
Astex Therapeutics Limited |
Hydroxybenzamide derivatives and their use as inhibitors of hsp90
|
AU2006236557A1
(en)
|
2005-04-14 |
2006-10-26 |
Novartis Vaccines And Diagnostics Inc. |
2-amino-quinazolin-5-ones as HSP90 inhibitors useful in treating proliferation diseases
|
WO2006117669A1
(en)
|
2005-05-03 |
2006-11-09 |
Pfizer Inc. |
Amide resorcinol compounds
|
DE102005022977A1
(de)
|
2005-05-19 |
2006-12-07 |
Merck Patent Gmbh |
Phenylchinazolinderivate
|
FR2885904B1
(fr)
|
2005-05-19 |
2007-07-06 |
Aventis Pharma Sa |
Nouveaux derives du fluorene, compositions les contenant et utilisation
|
FR2886038B1
(fr)
|
2005-05-20 |
2008-02-01 |
Fasver Sa Sa |
Vignette adhesive souple de securite anti-falsification, document officiel comprenant une telle vignette et procede de fabrication de cette vignette
|
US7763728B2
(en)
|
2005-05-25 |
2010-07-27 |
4Sc Ag |
Tetrahydropyridothiophenes
|
JP2008542242A
(ja)
|
2005-05-25 |
2008-11-27 |
ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規のテトラヒドロピリドチオフェン
|
DE102005024245A1
(de)
|
2005-05-27 |
2006-11-30 |
Merck Patent Gmbh |
Thienopyridine
|
CA2610572A1
(en)
|
2005-06-20 |
2007-01-04 |
Ash Access Technology, Inc. |
Anti-clotting indwelling catheter
|
JP5221131B2
(ja)
|
2005-06-29 |
2013-06-26 |
協和発酵キリン株式会社 |
ベンゼノイドアンサマイシン誘導体
|
DE102005037733A1
(de)
|
2005-08-10 |
2007-02-15 |
Merck Patent Gmbh |
Adeninderivate
|
WO2007022042A2
(en)
|
2005-08-11 |
2007-02-22 |
Novartis Ag |
Combinations comrising a protein kinase inhibitor being a pyrimidylaminobξnzamide compound and a hsp90 inhibitor such as 17-aag
|
US8629285B2
(en)
|
2005-08-18 |
2014-01-14 |
Synta Pharmaceuticals Corp. |
Imidazole compounds that modulate HSP90 activity
|
GB0519245D0
(en)
|
2005-09-20 |
2005-10-26 |
Vernalis R&D Ltd |
Purine compounds
|
JO2783B1
(en)
|
2005-09-30 |
2014-03-15 |
نوفارتيس ايه جي |
Compounds 2-Amino-7, 8-dihydro-6H-Bayredo (3,4-D) Pyrimidine-5-Ones
|
US7745893B2
(en)
|
2005-10-17 |
2010-06-29 |
Northern Lights Semiconductor Corp. |
Magnetic transistor structure
|
US20070105862A1
(en)
|
2005-11-10 |
2007-05-10 |
Milan Bruncko |
Heat-shock protein binders
|
EP1954265A2
(en)
|
2005-12-01 |
2008-08-13 |
Conforma Therapeutics Corporation |
Compositions containing ansamycin
|
KR20080078853A
(ko)
|
2005-12-24 |
2008-08-28 |
바이오티카 테크놀로지 리미티드 |
항암제로서 유용한 21-데옥시막베신 유사체
|
EP2012791A4
(en)
|
2006-02-07 |
2010-09-22 |
Conforma Therapeutics Corp |
7,9-DIHYDRO-PURIN-8-ONE AND RELATED ANALOGUES AS INHIBITORS OF HSP90
|
WO2007098229A2
(en)
|
2006-02-21 |
2007-08-30 |
Michigan State University |
Geldanamycin derivatives and method of use thereof
|
KR20090007319A
(ko)
|
2006-03-11 |
2009-01-16 |
베르날리스 (알 앤드 디) 리미티드 |
Hsp90 억제제로서 사용되는 피롤로피리미딘 유도체
|
WO2007117466A2
(en)
|
2006-03-31 |
2007-10-18 |
Massachusetts Institute Of Technology |
Celastrol, gedunin, and derivatives thereof as hsp90 inhibitors
|
RU2008141356A
(ru)
|
2006-04-26 |
2010-06-10 |
Ф. Хоффманн-Ля Рош Аг (Ch) |
Производные пиримидина в качестве ингибиторов фосфатидилинозитол-3-киназы (pi3k)
|
JP2009536186A
(ja)
|
2006-05-08 |
2009-10-08 |
アステックス・セラピューティクス・リミテッド |
癌処置のためのジアゾール誘導体の医薬組合せ
|
GB0609117D0
(en)
|
2006-05-09 |
2006-06-21 |
Biotica Tech Ltd |
Novel compounds
|
AU2007247121A1
(en)
|
2006-05-09 |
2007-11-15 |
Biotica Technology Limited |
18,21-didesoxymacbecin derivatives for the treatment of cancer
|
WO2007134298A2
(en)
|
2006-05-12 |
2007-11-22 |
Myriad Genetics, Inc. |
Therapeutic compounds and their use in cancer
|
DE102006023336A1
(de)
|
2006-05-18 |
2007-11-22 |
Merck Patent Gmbh |
1,5-Diphenyl-pyrazole II
|
DE102006023337A1
(de)
|
2006-05-18 |
2007-11-22 |
Merck Patent Gmbh |
Triazolderivate II
|
JP5441691B2
(ja)
|
2006-05-25 |
2014-03-12 |
シンタ ファーマシューティカルズ コーポレーション |
Hsp90活性を調節するトリアゾール化合物
|
US8183384B2
(en)
|
2006-05-25 |
2012-05-22 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate HSP90 activity
|
US8034834B2
(en)
|
2006-05-25 |
2011-10-11 |
Synta Pharmaceuticals Corp. |
Method for treating proliferative disorders with HSP90 inhibitors
|
CA2653327A1
(en)
|
2006-05-25 |
2007-12-06 |
Synta Pharmaceuticals Corp. |
Compounds that modulate hsp90 activity and methods for identifying same
|
TW200804313A
(en)
|
2006-05-25 |
2008-01-16 |
Synta Pharmaceuticals Corp |
Triazole compounds that modulate HSP90 activity
|
WO2007139952A2
(en)
|
2006-05-25 |
2007-12-06 |
Synta Pharmaceuticals Corp. |
Method for the preparation of triazole compounds with hsp90 modulating activity
|
EP2026653A4
(en)
|
2006-05-26 |
2011-11-16 |
Regado Biosciences Inc |
ADMINISTRATION OF REG1 ANTICOAGULATION SYSTEM
|
AR061185A1
(es)
|
2006-05-26 |
2008-08-13 |
Chugai Pharmaceutical Co Ltd |
Compuestos heterociclicos como inhibidores de hsp90. composiciones farmaceuticas.
|
WO2008150302A1
(en)
|
2007-06-04 |
2008-12-11 |
Nexgenix Pharmaceuticals |
Treatment of neurofibromatosis with radicicol and its derivatives
|
DE102006030479A1
(de)
|
2006-07-01 |
2008-03-20 |
Merck Patent Gmbh |
Indazolderivate
|
WO2008021213A1
(en)
|
2006-08-11 |
2008-02-21 |
Nicolas Winssinger |
Macrocyclic compounds useful as inhibitors of kinases and hsp90
|
AU2007285735A1
(en)
|
2006-08-16 |
2008-02-21 |
4Cs Ag |
Tetrahydrobenzothiophene derivatives
|
EP2051983A1
(en)
|
2006-08-16 |
2009-04-29 |
4Sc Ag |
Ntetrahydropyridothiophene derivatives for the treatment of cancer
|
WO2008021364A2
(en)
|
2006-08-17 |
2008-02-21 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate hsp90 activity
|
US20090093452A1
(en)
|
2006-08-24 |
2009-04-09 |
Pfizer Inc. |
Pyrrole, Thiophene, Furan, Imidazole, Oxazole, and Thiazole Derivatives
|
US7678803B2
(en)
|
2006-08-24 |
2010-03-16 |
Serenex, Inc. |
Quinazoline derivatives for the treatment of cancer
|
US20080070930A1
(en)
|
2006-08-24 |
2008-03-20 |
Huang Kenneth H |
Pyrimidine and Pyrazine Derivatives
|
US20080119457A1
(en)
|
2006-08-24 |
2008-05-22 |
Serenex, Inc. |
Benzene, Pyridine, and Pyridazine Derivatives
|
US20080070918A1
(en)
|
2006-08-24 |
2008-03-20 |
Huang Kenneth H |
Dihydropyridazine, Tetrahydropyridine, Chromanone, and Dihydronaphthalenone Derivatives
|
US20080070933A1
(en)
|
2006-08-24 |
2008-03-20 |
Huang Kenneth H |
Purine, Pyrimidine, and Azaindole Derivatives
|
BRPI0717176A2
(pt)
|
2006-09-19 |
2013-10-15 |
Daiichi Sankyo Co Ltd |
Composto, inibidores de hsp90, da atividade de atpase de hsp90 e da ligação de hsp90 a atp, medicamento, agente anticâncer, composição farmacêutica, método para tratar câncer, e, uso do composto
|
GB0620259D0
(en)
|
2006-10-12 |
2006-11-22 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
CL2007002994A1
(es)
|
2006-10-19 |
2008-02-08 |
Wyeth Corp |
Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
|
US20110046125A1
(en)
|
2006-10-19 |
2011-02-24 |
Synta Pharmaceuticals Corp. |
Method for treating infections
|
FR2907453B1
(fr)
|
2006-10-24 |
2008-12-26 |
Sanofi Aventis Sa |
Nouveaux derives du fluorene,compositions les contenant et utilisation
|
US20100280032A1
(en)
|
2006-10-26 |
2010-11-04 |
Synta Pharmaceuticals Corp. |
Method for treating inflammatory disorders
|
WO2008053319A1
(en)
|
2006-10-30 |
2008-05-08 |
Pfizer Products Inc. |
Amide resorcinol compounds
|
GB0622084D0
(en)
|
2006-11-06 |
2006-12-13 |
Chroma Therapeutics Ltd |
Inhibitors of HSP90
|
WO2008059368A2
(en)
|
2006-11-17 |
2008-05-22 |
Pfizer Products Inc. |
Fused 2-amino pyrimidine compounds and their use for the treatment of cancer
|
PE20081506A1
(es)
|
2006-12-12 |
2008-12-09 |
Infinity Discovery Inc |
Formulaciones de ansamicina
|
KR100872664B1
(ko)
|
2006-12-15 |
2008-12-10 |
현대자동차주식회사 |
실린더 내 마찰재가 부착된 에어컨 컴프레서
|
DE102007002715A1
(de)
|
2007-01-18 |
2008-07-24 |
Merck Patent Gmbh |
Triazolderivat
|
CN101652365A
(zh)
|
2007-02-01 |
2010-02-17 |
阿斯利康(瑞典)有限公司 |
作为hsp90抑制剂的5,6,7,8-四氢蝶啶衍生物
|
EA200970669A1
(ru)
|
2007-02-06 |
2010-02-26 |
Пфайзер Инк. |
Производные 2-амино-5,7-дигидро-6н-пирроло[3,4-d]пиримидина в качестве ингибиторов hsp-90, предназначенные для лечения рака
|
MX2009008547A
(es)
|
2007-02-08 |
2010-01-15 |
Synta Pharmaceuticals Corp |
Compuestos de triazol que son utiles en el tratamiento de trastornos proliferativos tales como cancer.
|
TW200904417A
(en)
|
2007-02-20 |
2009-02-01 |
Synta Pharmaceuticals Corp |
Triazole compounds that modulate Hsp90 activity
|
CL2008000629A1
(es)
|
2007-03-01 |
2008-08-29 |
Chugai Pharmaceutical Co Ltd |
Compuestos macrociclicos derivados de 6-aril-4-mercapto-[1.3.5]triazina/[1.3]pirimidin-2-amina; composicion farmaceutica, utiles en el tratamiento del cancer.
|
WO2008110508A1
(en)
*
|
2007-03-09 |
2008-09-18 |
Glaxo Group Limited |
Pyrrolo-pyridine derivatives for the treatment of disorders associated with inappropriate ikk1 activity
|
WO2008112199A1
(en)
|
2007-03-12 |
2008-09-18 |
Synta Pharmaceuticals Corp. |
Method for inhibiting topoisomerase ii
|
US20080234297A1
(en)
|
2007-03-20 |
2008-09-25 |
Changgeng Qian |
HSP90 Inhibitors Containing a Zinc Binding Moiety
|
RS52978B
(en)
|
2007-03-20 |
2014-02-28 |
Curis, Inc. |
FUSIONED AMINO PIRIDIN AS HSP90 INHIBITORS
|
EP2155694B1
(en)
|
2007-03-27 |
2012-01-04 |
Synta Pharmaceuticals Corp. |
Triazinone and diazinone derivatives useful as hsp90 inhibitors
|
JP2010524950A
(ja)
|
2007-04-16 |
2010-07-22 |
セレネックス, インコーポレイテッド |
テトラヒドロインドールおよびテトラヒドロインダゾール誘導体
|
GB2449293A
(en)
|
2007-05-17 |
2008-11-19 |
Evotec |
Compounds having Hsp90 inhibitory activity
|
FR2916443B1
(fr)
|
2007-05-24 |
2012-08-03 |
Sanofi Aventis |
Nouveaux derives analogues de l'herbimycine a, compositions les contenant et utilisation.
|
DE102007028521A1
(de)
|
2007-06-21 |
2008-12-24 |
Merck Patent Gmbh |
Indazolamidderivate
|
WO2009007399A1
(en)
|
2007-07-12 |
2009-01-15 |
Crystax Pharmaceuticals, S.L. |
New compounds as hsp90 inhibitors
|
DE102007032739A1
(de)
|
2007-07-13 |
2009-01-15 |
Merck Patent Gmbh |
Chinazolinamidderivate
|